• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Anorectic efficacy of the fenfluramine/phentermine combination in rats: additivity or synergy?

作者信息

Roth J D, Rowland N E

机构信息

University of Florida, Gainesville 32611-2250, USA.

出版信息

Eur J Pharmacol. 1999 Jun 4;373(2-3):127-34. doi: 10.1016/s0014-2999(99)00235-6.

DOI:10.1016/s0014-2999(99)00235-6
PMID:10414430
Abstract

Fenfluramine + phentermine was a widely used combination for weight loss. Fenfluramine and phentermine are believed to act via serotonin and catecholamines, respectively. To what extent these drugs interact has not been well-established. We compared the anorectic efficacy of a range of doses of the combination (using dexfenfluramine instead of fenfluramine) relative to a range of doses of the individual drugs in 90 min sweetened milk intake tests in deprived and nondeprived rats. Results were plotted on isobolograms to determine whether the anorectic effects of the combination were either additive or synergistic. Collectively, the isobolographic analysis revealed that: (1) under acute conditions, dexfenfluramine and phentermine interact for the most part in a synergistic manner, and (2) with the exception of phentermine alone, deprivation state at time of testing did not alter the efficacy of the anorectics. These findings suggest that combined drug treatment for obesity is a theoretical approach that merits further investigation.

摘要

相似文献

1
Anorectic efficacy of the fenfluramine/phentermine combination in rats: additivity or synergy?
Eur J Pharmacol. 1999 Jun 4;373(2-3):127-34. doi: 10.1016/s0014-2999(99)00235-6.
2
Investigating interactions between phentermine, dexfenfluramine, and 5-HT2C agonists, on food intake in the rat.研究苯丁胺、右芬氟拉明和5-羟色胺2C受体激动剂之间对大鼠食物摄入量的相互作用。
Psychopharmacology (Berl). 2015 Jun;232(11):1973-82. doi: 10.1007/s00213-014-3829-2. Epub 2014 Dec 20.
3
Efficacy of administration of dexfenfluramine and phentermine, alone and in combination, on ingestive behavior and body weight in rats.右芬氟拉明和苯丁胺单独及联合给药对大鼠摄食行为和体重的影响。
Psychopharmacology (Berl). 1998 May;137(1):99-106. doi: 10.1007/s002130050598.
4
Effects of preexposure to dexfenfluramine, phentermine, dexfenfluramine-phentermine, or fluoxetine on sibutramine-induced hypophagia in the adult rat.预先暴露于右芬氟拉明、苯丁胺、右芬氟拉明-苯丁胺或氟西汀对成年大鼠西布曲明诱导的摄食减少的影响。
Pharmacol Biochem Behav. 2003 Apr;75(1):103-14. doi: 10.1016/s0091-3057(03)00045-5.
5
Synergistic interactions between fenfluramine and phentermine.芬氟拉明与苯丁胺之间的协同相互作用。
Int J Obes Relat Metab Disord. 1999 Jul;23(7):723-32. doi: 10.1038/sj.ijo.0800920.
6
Effects of fenfluramine and phentermine (fen-phen) on dopamine and serotonin release in rat striatum: in vivo microdialysis study in conscious animals.芬氟拉明和苯丁胺(芬-苯合剂)对大鼠纹状体中多巴胺和5-羟色胺释放的影响:清醒动物体内微透析研究
Brain Res. 1998 Nov 30;813(1):67-72. doi: 10.1016/s0006-8993(98)01003-8.
7
Anesthetic considerations for the new antiobesity medications.新型抗肥胖药物的麻醉注意事项。
AANA J. 1996 Dec;64(6):541-4.
8
Effects of anorectic drugs on food intake under progressive-ratio and free-access conditions in rats.食欲抑制药物对大鼠在渐进比率和自由进食条件下食物摄入量的影响。
J Exp Anal Behav. 2004 Nov;82(3):275-92. doi: 10.1901/jeab.2004.82-275.
9
Effects of acute administration of phentermine, alone or in combination with dexfenfluramine, on pain reactivity in the adult rat.
Pharmacol Biochem Behav. 2008 Sep;90(3):339-43. doi: 10.1016/j.pbb.2008.03.009. Epub 2008 Mar 25.
10
Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine.右芬氟拉明、氨基苯唑、苯丁胺和氟西汀对大鼠下丘脑5-羟色胺的影响。
Eur J Pharmacol. 2002 Jun 7;445(1-2):69-81. doi: 10.1016/s0014-2999(02)01751-x.

引用本文的文献

1
KSK-74: Dual Histamine H and Sigma-2 Receptor Ligand with Anti-Obesity Potential.KSK-74:具有抗肥胖潜力的双重组胺 H 和西格玛-2 受体配体。
Int J Mol Sci. 2022 Jun 24;23(13):7011. doi: 10.3390/ijms23137011.
2
D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell.D1和D2拮抗剂可逆转食欲抑制剂对大鼠伏隔核壳部体重减轻、食物摄入、运动及重新平衡峰电位抑制的作用。
J Neurophysiol. 2015 Jul;114(1):585-607. doi: 10.1152/jn.00012.2015. Epub 2015 May 13.
3
Investigating interactions between phentermine, dexfenfluramine, and 5-HT2C agonists, on food intake in the rat.
研究苯丁胺、右芬氟拉明和5-羟色胺2C受体激动剂之间对大鼠食物摄入量的相互作用。
Psychopharmacology (Berl). 2015 Jun;232(11):1973-82. doi: 10.1007/s00213-014-3829-2. Epub 2014 Dec 20.
4
Effect of (-)-trans-PAT, a novel 5-HT2C receptor agonist, on intake of palatable food in mice.新型5-HT2C受体激动剂(-)-反式-PAT对小鼠美味食物摄入量的影响。
Pharmacol Biochem Behav. 2008 Nov;91(1):176-80. doi: 10.1016/j.pbb.2008.07.004. Epub 2008 Jul 19.
5
Pharmacological approaches for the treatment of obesity.治疗肥胖症的药理学方法。
Drugs. 2002;62(6):915-44. doi: 10.2165/00003495-200262060-00005.